Seeking Alpha

The FDA approves Hologic's (HOLX) Cervista HTA system for use with the company's previously...

The FDA approves Hologic's (HOLX) Cervista HTA system for use with the company's previously approved Cervista human papillomavirus HR test. The technology is used to detect 14 high risk types of HPV that are associated with cervical cancer and precancerous lesions. Shares +1.2% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|